Skip to content
HowShorted

REGENXBIO Inc. short interest in 2018

In 2018, REGENXBIO Inc.'s disclosed short interest ran from 4.98% of shares outstanding on 12 Jan 2018 to 6.64% on 31 Dec 2018, a change of +1.66 percentage points. The year's high was 11.30% on 15 Jun 2018 and its low 4.48% on 31 Jan 2018, averaging 7.82% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 11.55 days on 28 Feb 2018. Full history: REGENXBIO Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026

Aggregate net short position time series for REGENXBIO Inc. in 2018

2018 in figures

Start of year
4.98% (12 Jan 2018)
End of year
6.64% (31 Dec 2018)
Change
+1.66 pp
High
11.30% (15 Jun 2018)
Low
4.48% (31 Jan 2018)
Average
7.82%
Highest days to cover
11.55 (28 Feb 2018)
SEC filings marked
9

Every report in 2018

REGENXBIO Inc. short interest in 2018
SettlementShort interestDays to coverFilings since previous
12 Jan 20184.98%2.07results (8-K)
31 Jan 20184.48%4.02
15 Feb 20187.41%8.16
28 Feb 20187.44%11.55
15 Mar 20186.47%4.2410-K filed, results (8-K)
29 Mar 20186.58%7.19
13 Apr 20187.58%3.33
30 Apr 20187.72%4.90
15 May 20187.37%4.9110-Q filed, results (8-K)
31 May 20187.77%5.34
15 Jun 201811.30%2.98
29 Jun 201810.75%3.83
13 Jul 201811.06%6.42
31 Jul 201810.16%6.72
15 Aug 20189.13%4.2910-Q filed, results (8-K)
31 Aug 20188.22%5.69
14 Sep 20187.46%4.91
28 Sep 20189.22%4.54
15 Oct 20189.11%5.91
31 Oct 20187.57%5.89
15 Nov 20186.05%4.6310-Q filed, results (8-K)
30 Nov 20186.16%5.84
14 Dec 20186.98%4.52
31 Dec 20186.64%3.43

See also: REGENXBIO Inc.'s full history · most shorted US stocks of 2018 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.